(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are REDITUS,SGPS, ATLANTIC SAPPHIRE, and AVANTIUM.

Financial Asset	Price	Change	Updated (EST)
REDITUS,SGPS (RED.LS)	0.04	23.33%	2024-09-13 12:23:50
ATLANTIC SAPPHIRE (ASA.OL)	0.72	20.32%	2024-09-13 12:24:48
AVANTIUM (AVTX.AS)	1.87	8.74%	2024-09-13 12:00:41
IBA (IBAB.BR)	13.46	8.55%	2024-09-13 12:20:13
AELIS FARMA (AELIS.PA)	4.70	8.29%	2024-09-13 12:45:14
LAVIDE HOLDING (LVIDE.AS)	0.25	7.76%	2024-09-13 12:02:47
PHOTOCURE (PHO.OL)	53.10	7.6%	2024-09-13 12:42:23
EKOPAK (EKOP.BR)	14.15	6.02%	2024-09-13 12:06:03
AKER HORIZONS (AKH.OL)	2.45	5.68%	2024-09-13 12:24:30
AKER CARBON CAPTUR (ACC.OL)	6.01	5.62%	2024-09-13 12:24:28

The three biggest losers today are HOFSETH BIOCARE, BENFICA, and MKB Nedsense.

Financial Asset	Price	Change	Updated (EST)
HOFSETH BIOCARE (HBC.OL)	1.88	-7.84%	2024-09-13 12:40:29
BENFICA (SLBEN.LS)	3.19	-5.62%	2024-09-13 12:23:00
MKB Nedsense (NEDSE.AS)	0.06	-5.51%	2024-09-13 12:02:54
IMMOBEL (IMMO.BR)	23.15	-5.33%	2024-09-13 12:20:20
CENERGY (CENER.BR)	9.11	-4.6%	2024-09-13 12:05:37
EQVA (EQVA.OL)	6.34	-4.52%	2024-09-13 12:26:08
TECHSTEP (TECH.OL)	11.35	-4.22%	2024-09-13 12:43:58
HYLORIS (HYL.BR)	4.80	-4%	2024-09-13 12:20:11
TEKNA HOLDING (TEKNA.OL)	5.02	-3.46%	2024-09-13 12:43:59
NEL (NEL.OL)	5.42	-3.38%	2024-09-13 12:41:27

Winners today

1. REDITUS,SGPS (RED.LS)

23.33% Price Change

Reditus, Sociedade Gestora de Participações Sociais, S.A., through its subsidiaries, provides business process outsourcing, IT outsourcing, and IT consulting services in Portugal and internationally. The company offers client services, including client, financial, human resource, doc, and facilities management, as well as other business process services; and IT infrastructure services and solutions in the areas of advisory, design, installation, and maintenance of systems and solutions, storage, network, and security. It also provides specialized outsourcing services in the areas of application development and maintenance, DBs and system administration, business intelligence and applications, telecom engineering and networks, and support and helpdesk; and information security services and solutions, as well as security managed services. In addition, the company offers enterprise content management services, solutions, and products for deployment of projects in scanning, document management, and workflow in multi-channel topologies; lean management services and solutions in practical application of diagnostic methodologies; and management and IT consulting services and solutions. Further, it is involved in the development, management, and maintenance of software applications and analytical solutions; and provision of cooperation and development services and solutions in the areas of corporate procurement, project management, and economic and social development, as well as training and personal development services. The company serves public, health, telecom, media, utilities, financial services, consumer, retail, and transportation sectors. The company was founded in 1966 and is headquartered in Lisbon, Portugal.

PSI ended the session with REDITUS,SGPS rising 23.33% to €0.04 on Friday while PSI rose 0.68% to €6,838.52.

Earnings Per Share

As for profitability, REDITUS,SGPS has a trailing twelve months EPS of €0.1.

PE Ratio

REDITUS,SGPS has a trailing twelve months price to earnings ratio of 0.37. Meaning, the purchaser of the share is investing €0.37 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, REDITUS,SGPS’s stock is considered to be oversold (<=20).

Volatility

REDITUS,SGPS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.14%, a negative 1.25%, and a positive 24.50%.

REDITUS,SGPS’s highest amplitude of average volatility was 8.83% (last week), 30.60% (last month), and 24.50% (last quarter).

Yearly Top and Bottom Value

REDITUS,SGPS’s stock is valued at €0.04 at 22:40 EST, under its 52-week high of €0.04 and way above its 52-week low of €0.01.

Volume

Today’s last reported volume for REDITUS,SGPS is 144652 which is 212.04% above its average volume of 46356.

More news about REDITUS,SGPS.

2. ATLANTIC SAPPHIRE (ASA.OL)

20.32% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE jumping 20.32% to €0.72 on Friday while Oslo Børs Benchmark Index_GI jumped 0.9% to €1,407.41.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-26.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Yearly Top and Bottom Value

ATLANTIC SAPPHIRE’s stock is valued at kr0.72 at 22:40 EST, way below its 52-week low of kr4.50.

Volatility

ATLANTIC SAPPHIRE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.06%, a negative 2.82%, and a positive 6.55%.

ATLANTIC SAPPHIRE’s highest amplitude of average volatility was 10.73% (last week), 8.88% (last month), and 6.55% (last quarter).

More news about ATLANTIC SAPPHIRE.

3. AVANTIUM (AVTX.AS)

8.74% Price Change

Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium R&D Solutions, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It offers furandicarboxylic acid, a building block for polyethylene furanoate (PEF); and PEF, a plant-based recyclable plastic for use as packaging material. The company also provides catalyst testing systems, including Flowrence that provides catalyst testing and adsorbents. In addition, it offers R&D system and refinery catalyst testing services. Further, the company develops ray technology to produce mono-ethylene glycol from industrial sugars; and dawn technology which converts non-food plant-based feedstock to industrial sugars and lignin. Additionally, it produces polyesters using plantMEG. The company was founded in 2000 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with AVANTIUM rising 8.74% to €1.87 on Friday while AEX-Index rose 0.71% to €899.60.

Earnings Per Share

As for profitability, AVANTIUM has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.88%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AVANTIUM’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 21.4M for the twelve trailing months.

More news about AVANTIUM.

4. IBA (IBAB.BR)

8.55% Price Change

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

BEL 20 ended the session with IBA rising 8.55% to €13.46 on Friday, after two successive sessions in a row of gains. BEL 20 rose 0.67% to €4,245.21, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, IBA has a trailing twelve months EPS of €0.27.

PE Ratio

IBA has a trailing twelve months price to earnings ratio of 49.85. Meaning, the purchaser of the share is investing €49.85 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.86%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 27, 2024, the estimated forward annual dividend rate is 0.17 and the estimated forward annual dividend yield is 1.57%.

Volatility

IBA’s last week, last month’s, and last quarter’s current intraday variation average was 3.45%, 0.40%, and 2.21%.

IBA’s highest amplitude of average volatility was 4.37% (last week), 2.47% (last month), and 2.21% (last quarter).

Volume

Today’s last reported volume for IBA is 56264 which is 141.71% above its average volume of 23277.

More news about IBA.

5. AELIS FARMA (AELIS.PA)

8.29% Price Change

Aelis Farma SA, a clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders. It is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; and AEF0217, a drug candidate, which is in phase I/II clinical trials to treat cognitive deficits observed in Down syndrome, as well as other cognitive impairments. The company was incorporated in 2013 and is headquartered in Bordeaux, France.

CAC 40 ended the session with AELIS FARMA rising 8.29% to €4.70 on Friday while CAC 40 jumped 0.41% to €7,465.25.

Earnings Per Share

As for profitability, AELIS FARMA has a trailing twelve months EPS of €-0.39.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -27.17%.

More news about AELIS FARMA.

6. LAVIDE HOLDING (LVIDE.AS)

7.76% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. is based in Amsterdam, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING jumping 7.76% to €0.25 on Friday while AEX-Index rose 0.71% to €899.60.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.02.

More news about LAVIDE HOLDING.

7. PHOTOCURE (PHO.OL)

7.6% Price Change

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira, as well as strategic agreement with Richard Wolf GmbH to develop and commercialize a next-generation 4K LED high-definition (HD) reusable flexible blue light cystoscope based on Richard Wolf's System blue technology. It sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PHOTOCURE jumping 7.6% to €53.10 on Friday, after three consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.9% to €1,407.41, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, PHOTOCURE has a trailing twelve months EPS of kr0.47.

PE Ratio

PHOTOCURE has a trailing twelve months price to earnings ratio of 112.98. Meaning, the purchaser of the share is investing kr112.98 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.66%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 212.5% and a drop 16.7% for the next.

More news about PHOTOCURE.

8. EKOPAK (EKOP.BR)

6.02% Price Change

Ekopak NV designs, builds, finances, and operates industrial water processing solutions in Belgium, France, and internationally. It operates in two segments, Water-as-a-Service (WaaS) and Non-WaaS. The company offers cooling and feed water, boiler and feed water, and process water treatment; corrosion control; ultra-filtration; legionella prevention; and disinfection. The company also supplies chemicals for internal water treatment for protection against corrosion of and deposits on steam boilers, hot water and heating circuits, drinking water circuits, and cooling towers and circuits. In addition, it designs, constructs, and optimizes various water treatment equipment, which include dosing stations, spraying systems, disinfection units, water softeners, decarbonation and demineralization units, reverse osmosis units, filtration units, iron and manganese removal units, activated carbon filtration units, and physico-chemical and biological wastewater stations, as well as online monitoring, and disinfection and acidity units. It serves to the pharmaceutical, cosmetic, chemical, food and beverage, and pulp and paper industries. Ekopak NV was incorporated in 1997 and is headquartered in Tielt, Belgium.

BEL 20 ended the session with EKOPAK jumping 6.02% to €14.15 on Friday while BEL 20 jumped 0.67% to €4,245.21.

Earnings Per Share

As for profitability, EKOPAK has a trailing twelve months EPS of €-0.21.

Volatility

EKOPAK’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.75%, a negative 1.17%, and a positive 1.30%.

EKOPAK’s highest amplitude of average volatility was 3.91% (last week), 1.49% (last month), and 1.30% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EKOPAK’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for EKOPAK is 10798 which is 194.7% above its average volume of 3664.

More news about EKOPAK.

9. AKER HORIZONS (AKH.OL)

5.68% Price Change

Aker Horizons ASA, through its subsidiaries, develops and invests in renewable energy and green technology private and public companies worldwide. The company offers modular and capture units for reducing and removing carbon dioxide emissions of various industries, including the cement, bio and waste-to-energy, gas-to-power and blue hydrogen segments. It also develops, owns, and operates industrial-scale hydrogen projects for industries, such as shipping, steel, and fertilizers; and operates onshore and offshore wind and solar power generation. The company was incorporated in 2020 and is based in Lysaker, Norway. Aker Horizons ASA operates as a subsidiary of Aker Capital ASA.

Oslo Børs Benchmark Index_GI ended the session with AKER HORIZONS jumping 5.68% to €2.45 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.9% to €1,407.41, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr0.71.

PE Ratio

AKER HORIZONS has a trailing twelve months price to earnings ratio of 3.46. Meaning, the purchaser of the share is investing kr3.46 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.14%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AKER HORIZONS’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for AKER HORIZONS is 1202180 which is 5.51% below its average volume of 1272390.

Volatility

AKER HORIZONS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.15%, a negative 0.37%, and a positive 1.92%.

AKER HORIZONS’s highest amplitude of average volatility was 1.99% (last week), 1.93% (last month), and 1.92% (last quarter).

More news about AKER HORIZONS.

10. AKER CARBON CAPTUR (ACC.OL)

5.62% Price Change

Aker Carbon Capture ASA provides products, technology, and solutions within the field of carbon capture technologies, utilization, and storage in Norway and internationally. The company's carbon capture process uses a mixture of water and organic amine solvents to absorb the CO2 that can be applied on emissions from various sources, including gas, coal, cement, refineries, and waste-to-energy through to hydrogen and other process industries. It offers carbon capture plants under the Just Catch, Big Catch, and Just Catch Offshore brands. The company markets its products to cement, biomass and waste-to-energy, gas-to power, and blue hydrogen sectors, as well as refining and process and pulp and paper industries. The company was incorporated in 2020 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with AKER CARBON CAPTUR rising 5.62% to €6.01 on Friday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.9% to €1,407.41, after two sequential sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, AKER CARBON CAPTUR has a trailing twelve months EPS of kr-0.28.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.58%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 57.8%, now sitting on 1.04B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

AKER CARBON CAPTUR’s EBITDA is 6.16.

Volume

Today’s last reported volume for AKER CARBON CAPTUR is 4383210 which is 45.57% above its average volume of 3011010.

Sales Growth

AKER CARBON CAPTUR’s sales growth is 90.1% for the present quarter and 86.6% for the next.

More news about AKER CARBON CAPTUR.

Losers Today

1. HOFSETH BIOCARE (HBC.OL)

-7.84% Price Change

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

Oslo Børs Benchmark Index_GI ended the session with HOFSETH BIOCARE dropping 7.84% to €1.88 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.9% to €1,407.41, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, HOFSETH BIOCARE has a trailing twelve months EPS of kr-0.3.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -95.34%.

Moving Average

HOFSETH BIOCARE’s worth is under its 50-day moving average of kr2.04 and way under its 200-day moving average of kr2.26.

Yearly Top and Bottom Value

HOFSETH BIOCARE’s stock is valued at kr1.88 at 22:40 EST, way under its 52-week high of kr3.18 and higher than its 52-week low of kr1.80.

More news about HOFSETH BIOCARE.

2. BENFICA (SLBEN.LS)

-5.62% Price Change

Sport Lisboa e Benfica – Futebol, SAD operates a sports club in Portugal. The company was founded in 1904 and is headquartered in Lisbon, Portugal. Sport Lisboa e Benfica – Futebol, SAD operates as a subsidiary of Sport Lisboa e Benfica SGPS SA.

PSI ended the session with BENFICA dropping 5.62% to €3.19 on Friday while PSI jumped 0.68% to €6,838.52.

Earnings Per Share

As for profitability, BENFICA has a trailing twelve months EPS of €1.54.

PE Ratio

BENFICA has a trailing twelve months price to earnings ratio of 2.07. Meaning, the purchaser of the share is investing €2.07 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.79%.

Volume

Today’s last reported volume for BENFICA is 13 which is 99.53% below its average volume of 2774.

More news about BENFICA.

3. MKB Nedsense (NEDSE.AS)

-5.51% Price Change

MKB Nedsense N.V. engages in the financing and lending of funds to natural persons and legal entities. It provides guarantees and/or other securities to third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.

AEX-Index ended the session with MKB Nedsense sliding 5.51% to €0.06 on Friday, following the last session’s upward trend. AEX-Index rose 0.71% to €899.60, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.73%.

More news about MKB Nedsense.

4. IMMOBEL (IMMO.BR)

-5.33% Price Change

Immobel SA engages in the real estate development business in Belgium, Luxembourg, France, Germany, Poland, and Spain. The company undertakes and manages office, residential, mixed, home, and leisure real estate projects. The company was formerly known as Allfin NV and changed its name to Immobel SA in June 2016. The company was incorporated in 1863 and is headquartered in Brussels, Belgium. Immobel SA operates as a subsidiary of A³ Capital NV.

BEL 20 ended the session with IMMOBEL sliding 5.33% to €23.15 on Friday, following the last session’s upward trend. BEL 20 jumped 0.67% to €4,245.21, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, IMMOBEL has a trailing twelve months EPS of €-3.73.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.99%.

More news about IMMOBEL.

5. CENERGY (CENER.BR)

-4.6% Price Change

Cenergy Holdings SA manufactures and sells aluminium, copper, cables, steel and steel pipes, and other related products in Belgium and internationally. It operates through two segments: Cables and Steel Pipes. The company offers submarine and land power, power distribution, high-voltage direct current, wind farm, industrial, network, telecommunication, data transmission, signalling and railway signalling, gauging and control, umbilicals, and optical fiber cables, as well as low, medium, high, and extra high voltage power cables; and fiber to the home cables. It also provides turnkey solutions, such as installation, repair and replacement, original equipment manufacturer, custom-adapted application, supervision, technical support, transport and storage, customer instruction and training, and spare parts. In addition, the company offers onshore and offshore pipelines for transportation of oil, gas, and hydrogen, as well as carbon capture and storage applications and casing pipes; and hollow structural section products which are primarily used in the construction, power and telecom cables, wires, and raw materials. It serves power grids, interconnections, offshore and onshore wind, solar energy, telecommunications and data transmission, oil and gas, and heavy industries. The company was founded in 1949 and is based in Brussels, Belgium. Cenergy Holdings SA operates as a subsidiary of Viohalco S.A.

BEL 20 ended the session with CENERGY dropping 4.6% to €9.11 on Friday while BEL 20 rose 0.67% to €4,245.21.

Earnings Per Share

As for profitability, CENERGY has a trailing twelve months EPS of €0.56.

PE Ratio

CENERGY has a trailing twelve months price to earnings ratio of 16.27. Meaning, the purchaser of the share is investing €16.27 for every euro of annual earnings.

Volume

Today’s last reported volume for CENERGY is 6459 which is 122.03% above its average volume of 2909.

More news about CENERGY.

6. EQVA (EQVA.OL)

-4.52% Price Change

Eqva ASA, provides technical solutions and services to maritime and land based industries in Norway and internationally. It operates in three segments: Products, Solutions & Renewables; Real Estate; and Other. The company provides technical installations to the land-based and maritime industry; and develops and operates small-scale hydropower plants. It also engages in real estate business. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was incorporated in 1999 and is headquartered in Kvinnherad, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQVA sliding 4.52% to €6.34 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.9% to €1,407.41, after two consecutive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, EQVA has a trailing twelve months EPS of kr0.26.

PE Ratio

EQVA has a trailing twelve months price to earnings ratio of 24.38. Meaning, the purchaser of the share is investing kr24.38 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.

Moving Average

EQVA’s worth is way above its 50-day moving average of kr2.92 and way above its 200-day moving average of kr3.07.

Volume

Today’s last reported volume for EQVA is 25580 which is 18.86% below its average volume of 31529.

Revenue Growth

Year-on-year quarterly revenue growth grew by 209.8%, now sitting on 594.65M for the twelve trailing months.

Volatility

EQVA’s last week, last month’s, and last quarter’s current intraday variation average was 1.28%, 1.23%, and 3.32%.

EQVA’s highest amplitude of average volatility was 1.89% (last week), 2.88% (last month), and 3.32% (last quarter).

More news about EQVA.

7. TECHSTEP (TECH.OL)

-4.22% Price Change

Techstep ASA operates as a mobile technology company in Norway, Sweden, Denmark, and Poland. The company offers device lifecycle management, mobile data capture, and mobile device management solutions; strategic and technical advisory services; and unified endpoint, endpoint, and application management services. It also provides mobile devices and accessories; and mobile management and security products. Techstep ASA was founded in 2016 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with TECHSTEP sliding 4.22% to €11.35 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.9% to €1,407.41, after two consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, TECHSTEP has a trailing twelve months EPS of kr-1.16.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.66%.

Volume

Today’s last reported volume for TECHSTEP is 22112 which is 69.28% below its average volume of 71984.

Moving Average

TECHSTEP’s value is below its 50-day moving average of kr12.35 and way higher than its 200-day moving average of kr9.92.

Volatility

TECHSTEP’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.33%, a negative 0.35%, and a positive 2.75%.

TECHSTEP’s highest amplitude of average volatility was 2.51% (last week), 3.34% (last month), and 2.75% (last quarter).

More news about TECHSTEP.

8. HYLORIS (HYL.BR)

-4% Price Change

Hyloris Pharmaceuticals SA engages in the research, development, and manufacture of pharmaceutical products to address unmet medical needs. The company offers Maxigesic IV, a combination of paracetamol and ibuprofen sodium dihydrate used for post-operative pain; Podofilox Gel, an antimycotic drug for the treatment of external genital and perianal warts caused by various types of the human papilloma virus; and Sotalol IV to treat atrial fibrillation. It also develops Aspirin IV and HY-074 IV to reduce the risk of morbidity and mortality associated with an emergency cardiac event, such as myocardial infarction or stroke; Milrinone ER for right heart failure due to left ventricular device; Dofetilide IV to treat atrial fibrillation; Metolazone IV for the treatment of salt and water retention, including edema accompanying congestive heart failure and renal diseases; and HY-075 IV to prevent and treat cardiovascular diseases. In addition, the company offers other value-added products comprising Tranexamic Acid Oral Rinse for preventing and treating excessive bleeding in patients on blood thinners undergoing dental procedures; Alenura to treat pain associated with interstitial cystitis/bladder pain syndrome; Miconazole/Domiphen Bromide cream for recurrent vulvovaginal candidiasis; PTX-252 to treat acute myeloid leukemia; Atomoxetine oral Liquid for the treatment of attention deficit hyperactivity disorder; HY-083 to treat idiopathic rhinitis; HY-088 for hypophosphatemia; HY-090 to treat burning mouth syndrome; and HY-091 for vulvar lichen sclerosis. The company was incorporated in 2012 and is headquartered in Liège, Belgium.

BEL 20 ended the session with HYLORIS dropping 4% to €4.80 on Friday while BEL 20 rose 0.67% to €4,245.21.

Earnings Per Share

As for profitability, HYLORIS has a trailing twelve months EPS of €-0.55.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -33.08%.

Volatility

HYLORIS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.84%, a negative 2.15%, and a positive 7.53%.

HYLORIS’s highest amplitude of average volatility was 5.84% (last week), 4.28% (last month), and 7.53% (last quarter).

Volume

Today’s last reported volume for HYLORIS is 23922 which is 5.74% above its average volume of 22622.

Moving Average

HYLORIS’s worth is way below its 50-day moving average of €8.64 and way below its 200-day moving average of €11.25.

More news about HYLORIS.

9. TEKNA HOLDING (TEKNA.OL)

-3.46% Price Change

Tekna Holding ASA engages in the development, manufacture, and sale of micron and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel, silicon, and copper nanopowders, as well as boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.

Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING sliding 3.46% to €5.02 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.9% to €1,407.41, after two sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.36%.

Volatility

TEKNA HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.30%, a negative 1.19%, and a positive 3.88%.

TEKNA HOLDING’s highest amplitude of average volatility was 3.70% (last week), 3.73% (last month), and 3.88% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TEKNA HOLDING’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

TEKNA HOLDING’s stock is valued at kr5.02 at 22:40 EST, way below its 52-week high of kr9.38 and way above its 52-week low of kr4.40.

Moving Average

TEKNA HOLDING’s worth is way under its 50-day moving average of kr5.71 and way below its 200-day moving average of kr6.76.

More news about TEKNA HOLDING.

10. NEL (NEL.OL)

-3.38% Price Change

Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment manufactures hydrogen fueling stations for fuel cell electric vehicles, such as cars, buses, trucks, and other on-road vehicles. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industries, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEL falling 3.38% to €5.42 on Friday while Oslo Børs Benchmark Index_GI rose 0.9% to €1,407.41.

Earnings Per Share

As for profitability, NEL has a trailing twelve months EPS of kr-0.35.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.06%.

Moving Average

NEL’s worth is below its 50-day moving average of kr5.79 and under its 200-day moving average of kr5.81.

More news about NEL.

Stay up to date with our winners and losers daily report